William K. Heiden
2014
In 2014, William K. Heiden earned a total compensation of $2.7M as Chief Executive Officer at AMAG Pharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $579,200 |
|---|---|
| Option Awards | $838,666 |
| Salary | $534,610 |
| Stock Awards | $698,378 |
| Other | $7,800 |
| Total | $2,658,654 |
Heiden received $838.7K in option awards, accounting for 32% of the total pay in 2014.
Heiden also received $579.2K in non-equity incentive plan, $534.6K in salary, $698.4K in stock awards and $7.8K in other compensation.
Rankings
In 2014, William K. Heiden's compensation ranked 3,419th out of 13,032 executives tracked by ExecPay. In other words, Heiden earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,419 out of 13,032 | 74th |
Division Manufacturing | 1,209 out of 4,966 | 76th |
Major group Chemicals And Allied Products | 393 out of 1,686 | 77th |
Industry group Drugs | 306 out of 1,365 | 78th |
Industry Pharmaceutical Preparations | 249 out of 1,043 | 76th |
Source: SEC filing on April 20, 2017.
Heiden's colleagues
We found four more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2014.